Parkman Healthcare Partners LLC
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1777015
STAMFORD, CT
Position in AMLX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,162,124
-$1,476,142 QoQ
Shares Held
398,782
-35.8% QoQ
Ownership
0.358%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
#44
of 205 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Parkman Healthcare Partners LLC holds $82,007,868 across 7 Drug Manufacturers - Specialty & Generic names. AMLX ranks #6 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
202,907 | $16,796,641 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,624,279 | $16,242,790 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
364,269 | $14,945,957 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,807,621 | $14,316,358 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
541,190 | $9,367,998 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
398,782 | $7,162,124 | |
| 7 | VTRS |
Viatris Inc
|
200,000 | $3,176,000 |
All Filings in AMLX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,162,124 | 398,782 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,638,266 | 621,458 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,611,660 | 381,760 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,870,974 | 579,174 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,166,500 | 650,000 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||